ABHI UK HealthTech Conference 2026
About this Event
The ABHI UK HealthTech Conference returns in 2026, bringing together leaders from industry, government, the NHS, and regulation for two days of essential updates, market intelligence, and networking.
As the UK looks to strengthen its position as a global destination for HealthTech innovation, companies continue to face a rapidly evolving landscape for both regulation and market adoption. From international regulatory alignment and AI oversight to NHS access pathways and system readiness, organisations must navigate increasing complexity while demonstrating value, evidence, and impact at pace.
Taking place across two dedicated days, the 2026 Conference will provide practical insight into the policy, regulatory, and commercial environment shaping HealthTech in the UK, alongside direct engagement with the individuals and institutions driving change.
Day One will focus on regulation, exploring the UK regulatory offer, recognition and reliance, early engagement with the MHRA, digital regulation, AI, post-market surveillance, and the role of evidence, transparency, and patient trust in modern regulatory systems.
Day Two will turn to market access and adoption, examining the national policy environment, NICE and NHS access pathways, investment and commercial decision-making, local system adoption, procurement, digital transformation, and the capabilities needed to deliver innovation at scale across health and care.
With more than 200 senior participants expected each day, the Conference offers an invaluable opportunity to connect with peers, hear directly from policymakers and system leaders, and gain practical insight into the opportunities and challenges shaping the next phase of UK HealthTech growth.
Whether your focus is regulatory strategy, NHS adoption, investment, or commercial growth, the ABHI UK HealthTech Conference 2026 is the place to understand what comes next, and how to position your organisation for success.
Agenda
9th November 2026 - Day 1
09:15 I Registration & Coffee
10:00 I Welcome
- Steve Lee - Executive Director, Regulation, ABHI
10:15 I Keynote: The UK's Global Regulatory Offer
- Lawrence Tallon - Chief Executive Officer, MHRA
11:00 I Recognition & Reliance in Practice
- Rob Reid - Deputy Director, Innovative Devices, MHRA
- Cait Gatt - Associate Director, Quality & Regulatory Affairs, BD
- Jonathan Ripley - Managing Director, IMed Consultancy Ltd
- Megha Iyer - Senior Director, Corporate Regulatory Affairs, Thermo Fisher Scientific
11:45 I Coffee Break
12:15 I Outputs from the AI Commission
- Prof Alastair Denniston - Professor of Regulatory Science and Innovation, University of Birmingham
- Nina Goddard - Senior RAQA Manager, Intuitive
- Gabbie Cesvet - Head of Public Affairs, Scarlet
- Andrew Davies - Executive Director, Digital Health, ABHI
13:00 I Lunch
14:00 I Digitalisation & The Future of Regulation
- James Shearn - Director, Regulatory Intelligence & Policy, Steris
- Diogo Geraldes PHD - Director, Regulatory Strategy - EU MedTech, Veeva Systems
- Amra Racic - Global VP of Government and Policy Strategy, Veeva MedTech
- Michael King - Senior Director, Product & Strategy IQVIA
- Sinead Quaid - Director, Regulatory Affairs, Cook Medical
15:00 I Coffee Break
15:45 I Post Market Surveillance To Market Access
- Jillan Hussein - Senior Assessor (Benefit Risk Evaluation), MHRA
- Roland Back - Director Regulatory Affairs EMEA, Abbott
- Darren Thain - Director of Global Regulatory Intelligence and Policy, Smith + Nephew
- Lionel Tussau - Lead Healthcare, BYRD Health (an osapiens company)
- Sue Spencer - Founder Director, Compliance Connextions
16:45 I Closing Remarks
17:00 I Close
10th November 2026 - Day 2
09:15 I Registration & Coffee
10:00 I Welcome
- Luella Trickett - Executive Director, Medical Devices, Value and Access, ABHI
10:15 I The Market Access Environment
- Will Warburton - Director of Life Science Policy, NHS England
- David Lawson - Director of Medical Technology & Innovation, Department of Health and Social Care
- Chris Leech MBE - Director of Engagement & Social Value Impact, Rebuilding Future Alliance
11:00 I System Leadership & Local Adoption
- Pia Larsen - Procurement Director Guys & St Thomas Hospital
- Rakesh Uppal - CEO, Barts Life Sciences
- Jeff Bousfield - CEO, Nonacus
11:45 I Coffee Break
12:15 I Investment & Commercial Decisions
- Steve Bates OBE - Executive Chair, Office for Life Sciences
- Julia Hammac - General Manager, Diabetes Care, Abbott
- Ashley Sweetland MBE - Vice President, Head of Global Corporate Affairs, Convatec
- Peter Worrallo - Consultant, Penlon Limited
- David Porter - Founding Partner, Apposite Capital LLP
13:00 I Lunch
14:00 I NICE, NHSE & National Access Pathways
- Prof Jonathan Benger - Chief Executive Officer, NICE
- Joy Allen - Head of Market Access and Public Affairs, Roche Diagnostics
- Kristian Howells - Group Commercial Director, Medtronic
- Nicola Bent - CEO, Health Innovation Wessex
14:45 I Coffee Break
15:15 I Digital Health, Data & System Readiness
- Dr Muhammad Aslam - Consultant Pathologist & Clinical Director for North Wales Diagnostic and Specialist Clinical Service
- Robert Dale - Senior Programme Manager, Digital Diagnostics and AI, NHS England
- Dr Surbhi Gupta - Head of Software and AI medical devices, NHS England
16:00 I Neighbourhood Health: Getting Ready for the Future
- Dr Dan Gilpin - Medical Director, Leeds Teaching Hospitals NHS Trust
16:55 I Closing Remarks
17:00 I Close
Interested in becoming an exhibitor sponsor?
Write to [email protected] to explore your options.
Tickets
SMEs are categorised as businesses with under 250 staff.
For bookings of more than five delegates, multi-buy discounts can be offered. Please write to [email protected] for more information.
Please note that a list of attendees (name and organisation) will be made available to delegates in advance of the event. If you would prefer not to be included on this list, please contact us at [email protected]
With thanks to our 2026 Exhibitor Sponsors:
Where is it happening?
Event Location & Nearby Stays:
GBP 358.80 to GBP 778.80
